Parkinson’s Disease Treatment Market by Patient Care Setting

The major driving factors for this Parkinson’s Disease Treatment Market include ageing population and government funding for research, growing healthcare awareness.

The base year considered for the study is 2016, and the forecast has been provided for the period between 2018 and 2023.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

Hospital

Hospitals segment is estimated to account for the largest share of the Parkinson’s disease treatment market in 2017. This segment includes large, medium-sized, and small hospitals as well as critical care centers. Growth in this market can largely be attributed to the patient visits to hospitals are very high owing to the availability of diagnostic laboratories for diagnosing diseases; and presence of skilled professionals.

Presence of skilled professional in the hospital care setting drives the growth of parkinson’s disease treatment market

Clinics

Clinics, also known as outpatient clinics or ambulatory care clinics, are healthcare facilities where outpatients are treated. In comparison with hospitals, clinics are expected to hold a smaller share of the overall market in the coming years mainly due to the shortage of neurologists in these facilities. In addition, most clinics do not have in-house diagnostic laboratories, owing to which most patients prefer hospitals.

Key Players 

Teva (Israel), AbbVie (US), Boehringer Ingelheim (Germany) Lundbeck (Denmark), Acadia (US), Sun Pharma (India), US WorldMeds (US), Dr. Reddy’s (India), are the top players in this market. These companies have a broad product portfolio with comprehensive features and a strong geographical presence.

Target Audience for this Report:

  • Parkinson’s disease treatment product manufacturers
  • Parkinson’s disease treatment dealers and suppliers
  • Human identification service providers
  • Parkinson’s disease associations
  • Academic institutions
  • Venture capitalists

To Know More @ https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Share this post:

Related Posts

Comments are closed.